Dental equipment and supplies

Structure confirmed. Will ship with Certificate of Analysis (CoA)

Pre-loaded resin for synthesis of peptides containing C-terminal aspartic acid aldehyde. Associated Protocols and Technical Articles Cleavage and Deprotection Protocols for Fmoc SPPS Linkage Replaces: 04-12-3722 Legal Information NOVASYN is a

Pre-loaded resin for synthesis of peptides containing C-terminal aspartic acid aldehyde. Associated Protocols and Technical Articles Cleavage and Deprotection Protocols for Fmoc SPPS Linkage Replaces: 04-12-3722 Legal Information NOVASYN is a

Pre-loaded resin for synthesis of protected peptide acids containing a C-terminal glutamine amino-acid residue by Fmoc SPPS. Cleavage of the protected peptide is effected by treatment with 1% TFA in DCM or 20% TFE in DCM Associated Protocols and

Structure confirmed. Will ship with Certificate of Analysis (CoA)

Structure confirmed. Will ship with Certificate of Analysis (CoA)

Pre-loaded resin for synthesis of protected peptide acids containing a C-terminal histidine amino-acid residue by Fmoc SPPS. Cleavage of the protected peptide is effected by treatment with 1% TFA in DCM or 20% TFE in DCM Associated Protocols and

Pre-loaded resin for synthesis of protected peptide acids containing a C-terminal histidine amino-acid residue by Fmoc SPPS. Cleavage of the protected peptide is effected by treatment with 1% TFA in DCM or 20% TFE in DCM Associated Protocols and

H-Leu-2-ClTrt resin

Pre-loaded resin for synthesis of protected peptide acids containing a C-terminal leucine amino-acid residue by Fmoc SPPS. Cleavage of the protected peptide is effected by treatment with 1% TFA in DCM or 20% TFE in DCM Associated Protocols and

Pre-loaded resin for synthesis of peptides containing C-terminal leucinal. Associated Protocols and Technical Articles Cleavage and Deprotection Protocols for Fmoc SPPS Linkage Replaces: 04-12-3720 Analysis Note Color (visual): white to yellow to

Pre-loaded resin for synthesis of protected peptide acids containing a C-terminal methionine amino-acid residue by Fmoc SPPS. Cleavage of the protected peptide is effected by treatment with 1% TFA in DCM or 20% TFE in DCM Associated Protocols and